NewsRx

Search our medical news database

Greatbatch, Inc.

Component maker enters into a tantalum capacitor license agreement with Medtronic

Published in Law and Health Weekly, December 3rd, 2005

Greatbatch, Inc., (GB) announced that the company entered into a royalty-bearing licensing agreement with Medtronic, Inc.

This agreement grants Medtronic rights with respect to certain intellectual property relating to tantalum capacitors in exchange for an initial license fee payable on Medtronic's first U.S. sales and stipulated royalty payments.

The royalty payments are subject to an agreed-upon maximum and may be eliminated if Medtronic purchases a stipulated percentage of their tantalum capacitors from the company. The royalty periods are for 2 initial 5-year contract periods and may be extended if the royalty maximum is not met as long as...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook